Description
Escitam Asino (Escitalopram) Coated Tablets 20 mg. №60
Ingredients:
Each coated tablet contains 20 mg of escitalopram.
Mechanism of Action:
Escitam Asino acts as a selective serotonin reuptake inhibitor (SSRI), increasing serotonin levels in the brain. Serotonin, a neurotransmitter, plays a crucial role in mood and emotion regulation.
Pharmacological Properties:
Escitam Asino exerts its therapeutic effects by selectively inhibiting the reuptake of serotonin, enhancing neurotransmission in neural pathways associated with mood regulation.
Indications for Use:
Escitam Asino is indicated for the treatment of major depressive disorder and generalized anxiety disorder in adults.
Contraindications:
Avoid using Escitam Asino if you have a known allergy to escitalopram or citalopram.
Side Effects:
Common side effects of Escitam Asino may include nausea, insomnia, dizziness, and fatigue. Contact your healthcare provider if you experience severe side effects such as suicidal thoughts, mood changes, or allergic reactions.
Usage Instructions:
The recommended dosage is one 20 mg tablet daily, with or without food. Follow your healthcare provider’s instructions carefully and do not exceed the prescribed dose.
Benefits Compared to Analogues:
Escitam Asino offers comparable efficacy to other antidepressants with a favorable side effect profile. Its proven effectiveness in clinical trials makes it a preferred choice for many patients and healthcare providers.
Suitable Patient Groups:
Escitam Asino is suitable for adult patients with major depressive disorder or generalized anxiety disorder. Consult a healthcare provider for appropriate use in specific patient populations such as the elderly or those with comorbid conditions.
Storage Conditions and Shelf Life:
- Store Escitam Asino at room temperature, away from moisture and heat.
- Keep the medication out of reach of children and pets.
- Do not use Escitam Asino after the expiration date printed on the packaging.
Packaging Description:
Escitam Asino is available in blister packs containing 60 coated tablets of 20 mg each. The packaging is designed to maintain the stability and integrity of the tablets.
Clinical Evidence and Proven Effectiveness:
Escitalopram has been extensively studied in clinical trials, demonstrating its efficacy in the treatment of depression and anxiety disorders. Studies have shown that escitalopram is more effective than placebo in reducing depressive symptoms and is well-tolerated for long-term use in anxiety disorders.
For instance, a study published in the Journal of Clinical Psychiatry reported significant improvements in major depressive disorder symptoms with escitalopram compared to placebo. Another study in the Journal of Affective Disorders highlighted the efficacy and tolerability of escitalopram in generalized anxiety disorder treatment.
Overall, the scientific evidence supports the use of Escitam Asino as a reliable treatment option for individuals suffering from depression and anxiety disorders.
